|
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer |
|
|
|
Titel: |
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer |
Auteur: |
Schmidt, M. Scheulen, M.E. Dittrich, C. Obrist, P. Marschner, N. Dirix, L. Schmidt, M. Rüttinger, D. Schuler, M. Reinhardt, C. Awada, A. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 21 () nr. 2 pagina's 275-282 |
Jaar: |
2010 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|